Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821948 · ClinicalTrials.gov registry record
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 5,131
- Enrollment target
NCT03821948 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 5,131 participants.
The verdict
NCT03821948 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 5,131 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of colorectal cancer (CRC).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,131 participants |
| Start Date | 2019-01-03 |
| Est. Completion | 2020-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03821948
The ClinicalTrials.gov registry entry for NCT03821948 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03821948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03821948 about?
NCT03821948 is a clinical study titled "Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold". The primary objective of this study is to collect de-identified, clinically-characterized stool and whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of colorectal cancer (CRC).
What is the current status of trial NCT03821948?
This trial is currently completed. The enrollment target is 5,131 participants. The study started on 2019-01-03. Estimated completion is 2020-05-15.
Who is sponsoring clinical trial NCT03821948?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.